Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Author:

Murillo Perez Carla F.12ORCID,Hirschfield Gideon M.1,Corpechot Christophe3ORCID,Floreani Annarosa4,Mayo Marlyn J.5ORCID,van der Meer Adriaan2,Ponsioen Cyriel Y.6,Lammers Willem J.2,Parés Albert7,Invernizzi Pietro8ORCID,Carbone Marco8ORCID,Maria Battezzati Pier8,Nevens Frederik9,Kowdley Kris V.10,Thorburn Douglas11,Mason Andrew L.12ORCID,Trivedi Palak J.13,Lindor Keith D.14ORCID,Bruns Tony15,Dalekos George N.16,Gatselis Nikolaos K.16,Verhelst Xavier17,Janssen Harry L.A.1,Hansen Bettina E.1,Gulamhusein Aliya1,

Affiliation:

1. Toronto Ontario Canada

2. Rotterdam The Netherlands

3. Paris France

4. Padua Italy

5. Dallas TX USA

6. Amsterdam The Netherlands

7. Barcelona Spain

8. Milan Italy

9. Leuven Belgium

10. Seattle WA USA

11. London UK

12. Edmonton AB Canada

13. Birmingham UK

14. Phoenix AZ USA

15. Jena and Aachen Germany

16. Larissa Greece

17. Ghent Belgium

Funder

Intercept Pharmaceuticals

Foundation for Liver and Gastrointestinal Research

Cymabay Therapeutics Inc.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3